Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Shares Outstanding: 2011-2021

Historic Shares Outstanding for Agios Pharmaceuticals (AGIO) over the last 11 years, with Dec 2021 value amounting to $70.6 million.

  • Agios Pharmaceuticals' Shares Outstanding rose 0.89% to $71.0 million in Q2 2022 from the same period last year, while for Jun 2022 it was $71.0 million, marking a year-over-year increase of 0.89%. This contributed to the annual value of $70.6 million for FY2021, which is 1.81% up from last year.
  • Latest data reveals that Agios Pharmaceuticals reported Shares Outstanding of $70.6 million as of FY2021, which was up 1.81% from $69.3 million recorded in FY2020.
  • Over the past 5 years, Agios Pharmaceuticals' Shares Outstanding peaked at $70.6 million during FY2021, and registered a low of $48.8 million during FY2017.
  • Over the past 3 years, Agios Pharmaceuticals' median Shares Outstanding value was $69.3 million (recorded in 2020), while the average stood at $69.4 million.
  • Data for Agios Pharmaceuticals' Shares Outstanding shows a peak YoY grew of 19.24% (in 2018) over the last 5 years.
  • Over the past 5 years, Agios Pharmaceuticals' Shares Outstanding (Yearly) stood at $48.8 million in 2017, then grew by 19.24% to $58.2 million in 2018, then grew by 17.49% to $68.4 million in 2019, then grew by 1.31% to $69.3 million in 2020, then climbed by 1.81% to $70.6 million in 2021.